What is Flibanserin for Women?

Sexual health is an important part of every woman’s overall well-being. However, at certain times in their lives, many women experience decreased sexual desire, which can impact their self-esteem, relationships, and quality of life. Hypoactive sexual desire disorder (HSDD) is a medical condition characterized by persistent or recurrent deficiency or absence of sexual fantasy and desire, causing significant distress or interpersonal difficulties.

In the search for effective solutions to combat HSDD, the medical community has turned its attention to flibanserin, a non-hormonal drug designed specifically for women. In this comprehensive article, we will take a detailed look at what flibanserin is, how it works, its potential benefits and risks, and answer the most common questions to help you gain a full understanding of this drug.

What is Flibanserin?

Flibanserin, sold under the brand name Addyi , is the first and only drug approved by the U.S. Food and Drug Administration (FDA) to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It’s important to note that flibanserin is different from male sexual dysfunction drugs like Viagra. It works on neurotransmitters in the brain that control sexual desire rather than on blood flow.

Unlike hormonal drugs, flibanserin is a non-hormonal agent, making it unique in its approach to treating HSDD. Its development has become a significant breakthrough in women’s sexual health, providing women suffering from low sexual desire with an additional option to improve their intimate life.

Mechanism of action of flibanserin: How does it work?

Flibanserin belongs to a class of drugs known as selective serotonin receptor agonists/antagonists . It affects the balance of neurotransmitters in the brain, particularly serotonin and dopamine, which play a key role in regulating mood, emotion, and sexual desire.

Serotonin Inhibition: Flibanserin acts as a 5-HT1A receptor agonist and 5-HT2A receptor antagonist. Activation of 5-HT1A receptors and blockade of 5-HT2A receptors is thought to help reduce the inhibitory effect of serotonin on sexual desire.
Increased Dopamine and Norepinephrine Levels Although the mechanism of action of flibanserin is not fully understood, studies suggest that it may indirectly increase dopamine and norepinephrine levels in the prefrontal cortex of the brain. These neurotransmitters are associated with stimulation of sexual arousal and desire.

Thus, flibanserin helps restore the balance of neurotransmitters in the brain, helping to increase sexual desire in women with HSDD. It is important to emphasize that flibanserin is not a “female Viagra” and is not intended to instantly increase sexual arousal. It is a drug that is taken daily and is designed to gradually restore sexual desire over time.

Who is flibanserin indicated for?

Flibanserin is indicated for premenopausal women who meet the following criteria:

Diagnosis of Hypoactive Sexual Desire Disorder (HSDD): This means a persistent or recurrent deficiency or absence of sexual fantasy and desire that causes significant distress.
Acquired GSSD: The disorder must be acquired, that is, it must occur after a period of normal sexual function.
Generalized GSPD: The disturbance must be generalized, that is, not limited to certain situations, partners, or types of stimulation.
Not due to other causes: GSSP should not be the result of medical conditions, mental disorders, relationship problems, or side effects of medication.

It is important to note that flibanserin is not intended for:

Postmenopausal women.
Men.
Increased sexual desire in women without GSRS.
Treatment of sexual dysfunction caused by other factors (eg, relationship problems).

Before starting to take flibanserin, you should consult with your doctor to rule out other possible causes of decreased sexual desire and to make sure that the drug is appropriate for your particular case.

Flibanserin Benefits: What to Expect?

Clinical studies have shown that flibanserin can help women with HSDD experience the following benefits:

Increased sexual desire Many women taking flibanserin reported a moderate increase in sexual desire and fantasies.
Increased number of satisfying sexual events Studies have shown that women taking flibanserin reported an increase in the number of satisfying sexual events per month compared to placebo.
Reducing distress associated with low sexual desire: Flibanserin may help reduce feelings of frustration, anxiety, and depression associated with LSDD.

It is important to have realistic expectations about flibanserin. It is not a “magic pill” that will instantly restore your sex drive. The effects of flibanserin usually occur gradually over several weeks or months of use. In addition, the effectiveness of flibanserin may vary from person to person, and not all women will experience significant improvement.

Flibanserin Side Effects and Risks

Like any medicine, flibanserin can cause side effects. The most common side effects include:

Dizziness: Dizziness may occur, especially at the beginning of treatment.
Drowsiness: Flibanserin may cause drowsiness or tiredness.
Nausea: Some women may experience nausea.
Fatigue: feeling tired or weak.
Dry mouth.
Insomnia.
Anxiety.

Serious risks:

The most serious risk associated with flibanserin is its interaction with alcohol . Drinking alcohol while taking flibanserin can lead to severe hypotension (low blood pressure) and diarrhea . Because of this risk, the FDA has instituted a strict REMS (Risk Evaluation and Mitigation Strategy) program for flibanserin, which includes:

Physician Certification: Physicians must be certified to prescribe flibanserin.
Pharmacy Certification: Pharmacies must be certified to dispense flibanserin.
Informed Patient Consent: Patients must be fully informed of the risks of flibanserin, especially the interaction with alcohol, and sign an informed consent form.
Alcohol Restrictions Women taking flibanserin are strictly prohibited from drinking alcohol .

Other potential risks of flibanserin include:

Interactions with other medications Flibanserin may interact with certain medications, including antifungals, antidepressants, and some antibiotics. It is important to tell your doctor about all the medications you are taking before you start taking flibanserin.
Liver problems Flibanserin is not recommended for women with liver disease.

Before taking flibanserin, carefully discuss all potential risks and benefits with your doctor, and make sure you fully understand alcohol restrictions and other precautions.

How to take flibanserin?

Flibanserin is taken one 100 mg tablet daily before bedtime . Taking it before bedtime helps minimize daytime sleepiness. It is important to take flibanserin at about the same time each night .

It is strictly forbidden to drink alcohol while taking flibanserin . If you decide to drink alcohol, you must stop taking flibanserin that day. Do not skip a dose to drink alcohol.

If you miss a dose of flibanserin, do not take a double dose the next evening. Just take your next dose at your usual time.

The effectiveness of flibanserin should be assessed after 8 weeks of use . If you do not feel an improvement in your sexual desire after 8 weeks, contact your doctor. Flibanserin may not be effective for you, and your doctor may suggest other treatment options.

Regular consultations with your doctor while taking flibanserin are important to monitor the drug’s effectiveness, side effects, and to ensure safe and effective treatment.

History and development of flibanserin

The history of flibanserin is quite interesting and indicative of the development of drugs for women’s sexual health. Flibanserin was initially developed as an antidepressant . However, during clinical trials it was found that it was not effective in treating depression, but it may have a positive effect on sexual desire in women.

The first application for approval of flibanserin for the treatment of HSDD was submitted to the FDA in 2010, but was rejected due to lack of efficacy and safety concerns. After further study and review of the data, the FDA rejected the application twice before approving flibanserin in 2015 under the brand name Addyi.

The approval of flibanserin has generated considerable debate and controversy. Some experts have expressed doubts about its clinical value and potential risks, especially when compared with placebo. Others have hailed the approval of flibanserin as an important step forward in the recognition and treatment of female sexual dysfunction.

Since its approval, flibanserin has changed hands several times. It was first developed by Boehringer Ingelheim , then the rights were transferred to Sprout Pharmaceuticals , which was later acquired by Valeant Pharmaceuticals (now Bausch Health ).

Flibanserin versus alternative treatments for GSDP

Flibanserin is one treatment option for HSDD, but there are other approaches that may be effective for some women. Alternative treatments for HSDD include:

Psychotherapy: Sexual and cognitive behavioral therapy can help women understand the psychological and emotional factors that influence their sexual desire.
Lifestyle changes: Eating a healthy diet, exercising regularly, reducing stress, and getting enough sleep can have a positive impact on your overall well-being and sexual health.
Hormone therapy: In some cases, especially during menopause, hormone therapy (such as estrogen) may help restore sex drive, but it is not a first-line treatment for HSDD.
Other “off-label” medications: Sometimes doctors may prescribe other “off-label” medications to treat GSPD, although their effectiveness and safety for this purpose may be less well studied than flibanserin.

The choice of treatment for HSDD is individual and should be discussed with a doctor. Flibanserin may be an appropriate option for some women, particularly those who have not responded to other treatments or for whom psychotherapy is insufficient.

Is Flibanserin Right for You?

Flibanserin may be a treatment option for premenopausal women who:

Have a diagnosis of hypoactive sexual desire disorder (HSDD).
Suffer from significant distress due to low sexual desire.
We are prepared to comply with restrictions on alcohol consumption and other precautions.
Understand potential side effects and have realistic expectations of effectiveness.

Flibanserin is not suitable for women who:

Are postmenopausal.
There are sexual problems caused by reasons other than GSSP.
Have liver disease.
Take certain medications that flibanserin interacts with.
Not ready to completely give up alcohol.

If you are considering flibanserin as a treatment option, it is important to have an open discussion with your doctor about your symptoms, medical history, and lifestyle. Together, you can determine whether flibanserin is a safe and appropriate option for you and develop a personalized treatment plan that meets your needs.

Conclusion: Flibanserin – a step towards female sexual well-being

Flibanserin is the first and only FDA-approved, non-hormonal treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women. It represents a significant breakthrough in women’s sexual health, providing women with low sexual desire an additional option to restore sexual desire and improve their quality of life.

Although flibanserin is not a “magic pill” and has certain risks and limitations, for many women it can be an effective tool on the path to sexual well-being. It is important to remember that sexual health is a complex area, and flibanserin is only one element on the path to a harmonious and satisfying intimate life. Open communication with your doctor, understanding your needs, and an individualized approach to treatment are key to achieving positive results.